Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase 2 × Colonic Neoplasms × HuMax-IL8 × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Squamous Cell Carcinoma of Head and Neck 1 Pancreatic Neoplasms 1 Hematologic Neoplasms 1 Coronavirus Infections 1 Colonic Neoplasms 1 Carcinoma, Hepatocellular 1 COVID-19 1

Interventions

Fluorouracil 80 Oxaliplatin 73 Leucovorin 73 Irinotecan 68 Bevacizumab 45 Capecitabine 39 Cetuximab 36 Panitumumab 15 Folfox protocol 15 Floxuridine 11 Chemotherapy, Adjuvant 11 IFL protocol 9 Surgical Procedures, Operative 8 Neoadjuvant Therapy 8 Drug Therapy 8 trifluridine tipiracil drug combination 7 regorafenib 7 pembrolizumab 7 XELOX 7 Nivolumab 7 Radiotherapy 6 sargramostim 5 Trastuzumab 5 Melphalan 5 Immunohistochemistry 5 Dexamethasone 5 Celecoxib 5 Biopsy 5 tislelizumab 4 aflibercept 4

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03026140 2026-03-05

NICHE

The Netherlands Cancer Institute

Phase 2 Recruiting

Gastrointestinal

Colonic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡